Immunogenicity and safety of simplified vaccination schedules for the CYD-TDV dengue vaccine in healthy individuals aged 9-50 years (CYD65): a randomised, controlled, phase 2, non-inferiority study.
暂无分享，去创建一个
C. Diazgranados | M. R. Capeding | G. Dayan | B. Zambrano | F. Noriega | A. Cadena Bonfanti | M. Bonaparte | E. López-Medina | S. Savarino | M. L. A. Gonzales | M. C. Montalbán | Juliana Park | D. Coronel-MartÍnez | A. Rojas | Hao Wang | I. Ramírez | J. C. Ramírez | Mae Ann Verdan | Zhenghong Chen | Sunny Sun | Eduardo López-Medina | A. Á. Cadena Bonfanti